^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CD19-CAR-DNT

    i
    Other names: CD19-CAR-DNT
    Associations

    News

    Trials
    Company:
    Ruichuang Bio, Zhejiang Ruijiamei Biotech
    Drug class:
    CD19-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    over2years
    Clinical Study of the Efficacy of CD19-CAR-DNT Cells in the Treatment of Relapsed/Refractory B-cell NHL (clinicaltrials.gov)
    P1, N=12, Recruiting, Second Affiliated Hospital, School of Medicine, Zhejiang University
    New P1 trial
    |
    CD19 (CD19 Molecule)
    |
    CD20 negative
    |
    cyclophosphamide • CD19-CAR-DNT